Connect with us

Hi, what are you looking for?

Captain Of Success
Top Stories

Stock Markets

‘Side effect’ label on meds urged

PHILSTAR FILE PHOTO

THE Food and Drug Administration (FDA) should mandate drug companies to plaster warnings informing of possible side effects on the medical products they sell, a congressman said on Sunday.

“If cigarettes… have such labels, then it is only right that all medicinal products, especially those we ingest or inject into our bodies, should also have warning labels about adverse side effects,” Surigao del Norte Rep. Robert Ace S. Barbers said in a statement.

He said he’s willing to draft a bill requiring drug manufacturers to affix side effect warnings on medicines if the FDA has no compelling authority over them.

Mr. Barbers’ call for transparency about possible adverse medical events comes after he received concerns that prolonged use of some maintenance medication has led to further illness. — Kenneth Christiane L. Basilio

    You May Also Like

    Stock Markets

    The First Philippine Polymer Banknote Series is composed of the 1000-piso polymer banknote, as well as new polymer denominations: 500-, 100-, and 50-piso. —...

    Finance

    Homebase is set to return in a slimmed-down format after the DIY chain’s collapse last month, with its new owner CDS confirming plans to...

    Stock Markets

    When it comes to providing accommodations that have all the makings of a second home in the best Philippine destinations, Astoria Hotels and Resorts...

    Stock Markets

    No plan? No problem, as Absolut Vodka & SPRITE transforms the Philippines pulling off for the ultimate, unplanned hangout — celebrating the arrival of...

    Disclaimer: CaptainOfSuccess.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice.
    The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.